Virtual Meetings

Open-source acquisition and in-line reconstruction for MRS remain challenging due to vendor-specific sequence programming and reconstruction environments. These limitations complicate cross-platform implementation and maintenance of sequences, hinder large-scale multi-vendor studies, and reduce reproducibility. Recently, open-source pulse-sequence programming frameworks such as Pulseq and gammaSTAR have begun to address these barriers. Furthermore, vendors have created interfaces intended to streamline custom containerized reconstruction pipelines.

In this virtual meeting, we will discuss current open-source solutions across major scanner vendors and highlight features of two open-sequence platforms, along with user experiences. Join us to learn about the latest solutions from both industry and academia aimed at accelerating collaboration, standardization, and innovation in MRS.

This virtual meeting, hosted by the Renal MRI Study Group, is dedicated to advanced applications of T2- and diffusion-weighted MRI to quantify microstructural compartments (tubular, vascular, and parenchymal), and of chemical exchange saturation transfer (CEST) MRI to explore the distribution of metabolites in the kidney. The speakers will present their own cutting-edge work and review the latest developments on these topics. The intended audience of the virtual meeting are MRI physicists and radiologist researchers. The aim of the meeting is to inspire the study group membership and the wider ISMRM community to use established techniques in novel ways to explore the unique patho-physiology of the kidney.

This ISMRM MR Contrast Agents Study Group webinar will highlight recent advances and emerging clinical applications of ferumoxytol-enhanced MRI. Expert speakers will present cutting-edge work on the use of ferumoxytol for monitoring macrophage-activating immunotherapies, quantitative MRI of the pancreas, and expanding applications of ferumoxytol in body imaging. The session will conclude with a panel discussion on the recent approval of Ferabright and its implications for research, clinical translation, and future directions in MR contrast agent development.

Fetal MR neuroimaging plays an increasingly important role for early, in utero diagnosis of fetal pathology and subsequent patient management. MRI’s advanced diagnostic accuracy contributes to more informed prenatal counseling, optimizes timing and mode of delivery, directs potential fetal interventions, and guides strategies for perinatal management. Fetal MR, including high-resolution anatomic scans and diffusion tensor imaging (DTI), can help to confirm and further delineate CNS pathologies detected by surveillance fetal ultrasound, including ventriculomegaly, corpus callosum dysgenesis, holoprosencephaly, posterior fossa anomalies, intracranial hemorrhage, ischemic infarction, and vascular malformations. The integration of diffusion MRI/DTI to detect white-matter organization and integrity and hypoxic-ischemic damage has proven particularly valuable. Among the challenges of in utero fetal MRI are fetal and maternal motion, small anatomic structures, and the heterogenous placental/uterine environment, and various innovative strategies have been developed to help overcome them. This virtual meeting will provide attendees with an overview of state-of-the-art fetal MR neuroimaging techniques and their application to patient management.

Diffusion-weighted imaging (DWI) of the abdomen and pelvis have well-established roles in cancer detection and lesion characterization. Diffusion-based quantitative imaging biomarkers show promise in detecting clinically relevant histopathologic markers, such as microvascular invasion and parenchymal disease such as hepatic fibrosis. However, body DWI remains challenging due to high sensitivity to off-resonance and patient motion. A number of cutting-edge technologies, ranging from optimized diffusion encoding gradients to novel reconstruction pipelines, have emerged in the past decade and have been applied to body DWI. This seminar features expert clinicians and scientists who will outline the unmet challenges in body DWI, the existing and emerging solutions to these challenges, potential pathways for translating these solutions into clinical practice, and opportunities for artificial intelligence.

This virtual meeting will provide a preview of the ISMRT Annual Meeting.

Open science promotes transparency, reproducibility, and collaboration by enabling researchers to share data, code, and methodologies openly. This accelerates discovery, reduces duplicated effort, and builds trust in scientific results. These principles can strengthen MRI and radiation therapy research by supporting more robust methods, shared resources, and broader community participation.

In this virtual seminar, we will introduce the fundamentals of open science and discuss practical strategies for incorporating them into research workflows, present an example of an openly available dataset that demonstrates the value of shared resources, and showcase an open-source image reconstruction framework capable of real-time deployment. The session will end with a panel discussion on lessons learned, current limitations, and practical steps to expand the use of open science across the MR in RT community.